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doi:10.1016/j.jfma.2012.02.010Background/Purpose: A tourniquet is commonly used in limb surgery. Tourniquet inflation after
a period of time may produce painful sensation. While the mechanisms of tourniquet-induced
pain are still unknown, two components, pressure and ischemia, have been proposed. In this
study, in vivo microdialysis was used to detect changes in intrathecal glutamate, an excitatory
amino acid highly relevant to pain transmission, following hindlimb tourniquet application and
femoral artery occlusion in the rat.
Methods: Male Wistar rats were used. For the tourniquet study, 6 rats of the study group
received 30 minutes right hindlimb tourniquet inflation and another 6 rats as the control group
received only tourniquet application without inflation. In the femoral artery occlusion study, 6
rats of the study group received 30 minutes right femoral artery occlusion and another 6 rats as
the control group received only sham operation without femoral artery occlusion. Cerebro-
spinal fluid dialysates were collected prior to, during, and after tourniquet application or
femoral artery occlusion. Glutamate was measured by HPLC.
Results: A significant increase in intrathecal glutamate release was found during the tourni-
quet inflation period, and it returned to baseline after tourniquet deflation. No change of
glutamate release was noted during femoral artery occlusion or after femoral artery reperfu-
sion.
Conclusion: The intrathecal glutamate release was increased by the hindlimb tourniquet infla-
tion, but not influenced by femoral artery occlusion in the rat.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.t of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, No. 325,
, Taipei, Taiwan, R.O.C.
.com.tw (C.-H. Cherng).
ight ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
260 C.-H. Cherng et al.IntroductionA pneumatic tourniquet used on an extremity for operation
may induce a painful sensation during the maintenance of
inflation. The mechanism of this sensation, termed tour-
niquet pain, is not completely understood. Nerve
compression and arterial occlusion may produce clinical
pain problems, and both of them could be induced by
tourniquet inflation. Two components, pressure pain and
ischemic pain, have been proposed.1 Pressure pain is
caused by mechanic pressure of the cuff and felt at the site
of cuff. Ischemic pain is felt distally to the cuff and is
proposed to be caused by the accumulated metabolites
being produced in the ischemic tissue. Glutamate, an
excitatory amino acid, is a major neurotransmitter in the
central nervous system and plays an important role in both
normal and pathophysiological nociception.2 Glutamate is
released from the central terminals in the spinal cord upon
noxious stimulation. There are no previous reports inves-
tigating the relationship between tourniquet pain and
glutamate release in the spinal cord. In this study, we used
the in vivo microdialysis method to examine the glutamate
release in the cerebrospinal fluid under two situations in
the rat: hindlimb tourniquet inflation and femoral artery
occlusion.
Methods and materials
Animal preparation
Male Wistar rats (350e400 g) from the National Laboratory
Animal Center, Taiwan were used. The investigations were
performed using a protocol approved by the Institutional
Animal Care Committee of the National Defense Medical
Center, Taiwan. The rats were implanted with a micro-
dialysis probe that inserted via the cisternal membrane of
the C-spine and advanced caudally to the lumbar enlarge-
ment of the spinal cord. The ends of the microdialysis probe
were externalized and fixed to the cranial aspect of the
head. The rats then returned to their home cages for a 3-
day recovery period. The animals were maintained on
a 12-hour light/dark cycle with food and water freely
available. Rats showing any neurologic deficits after surgery
were excluded.
Construction of the spinal cord microdialysis probe
The intrathecal dialysis loop is constructed using two 7-cm
pressure-equalizing tubes (200-mm inner diameter, 356-mm
outer diameter) and a 4-cm cuprophan hollow fiber (300-mm
outer diameter, 200-mm inner diameter, 11-kDa molecular
weight cutoff; Filtral, AN 69-HF; Eicom Co., Kyoto, Japan).
A Nochrome-Formvar wire and the cuprophan hollow fiber
are connected to a PE-10 catheter with epoxy glue. The
middle portion of the cuprophan hollow fiber is bent to
form a U-shaped loop and both ends of the dialysis loop,
which consisted of silastic tubes, are sealed with silicone
sealant. During the in vivo measurements, the recovery
rate of the dialysis probe was 40% at an infusion rate of
5 ml/min.Tourniquet study
There were 2 groups allocated: the control group (nZ 6)
with no inflation of tourniquet and tourniquet group (nZ 6)
with tourniquet inflated by 300 mmHg. The animals were
anesthetized intraperitoneally with pentobarbital (50 mg/
kg). An inflatable pneumatic tourniquet (1 cm in width,
made by our medical engineering department) was applied
on the animal’s right hindlimb thigh, and was connected to
a sphygmomanometer. First, the baseline dialysates of both
groups were collected three times with 15-minute inter-
vals, then the tourniquet was inflated by 300 mmHg in the
tourniquet group and no tourniquet inflation was performed
in the control group. The dialysates of both groups were
collected during the following 30 minutes with tourniquet
inflation or not. After tourniquet deflation, the dialysates
of both groups were collected every 15 minutes for 30
minutes.
Femoral artery occlusion study
The two groups allocated were: the sham group (nZ 6)
with no femoral artery occlusion; and the ischemic group
(nZ 6) with femoral artery occlusion. The rats were
anesthetized intraperitoneally with pentobarbital (50 mg/
kg) and placed on a heated mat during the operation. Under
an operating microscope, after cutaneous incision of the
right inguinal region, the right femoral artery was exposed
and dissected free from the femoral vein and nerve. The
baseline dialysates of both groups were collected three
times with 15-minute intervals, then the femoral artery was
occluded by a vessel clip in the ischemic group and no
femoral artery occlusion was done in the sham group. In the
ischemic group complete arterial occlusion post vessel clip
application was checked by microscope. The dialysates of
both groups were collected during the following 30 minutes
with femoral artery occlusion or not. After this, the vessel
clip was removed and the dialysates of both groups were
collected every 15 minutes for 30 minutes. Reappearance
of femoral blood flow after removing the vessel clip was
checked by microscope in the ischemic group.
Microdialysis procedure and measurement of
glutamate
One of the dialysis tubes was connected to a syringe pump
(CMA-100) using a 30 cm length of PE-10 tubing (inflow), and
the otherwere connected to a 30 cmPE-10 tube (outflow) for
sample collection. Samples were collected in polypropylene
tubes on ice and frozen at e80C until analysis. The
concentrations of glutamate were measured by high-
performance liquid chromatography (HPLC; Agilent 1100;
Agilent Technologies, Wilmington, DE, USA) using a fluores-
cence detector (Gilson model 121, set at 428 nm; Gilson,
Inc., Middleton, WI, USA), as described previously.3 In brief,
amino acids were assayed by recolumn derivatization with o-
phthalaldehyde/t-butylthiol (OPA) reagent and iodoaceta-
mide/methanol scavenger. Derivatization was performed by
adding 4 ml of OPA reagent to 40 ml of sample, shaking the
mixture, then allowing it to react for 2 minutes. A 4 ml
aliquot of reagent B (185 mg of iodoacetamide/ml of
B I PI 15 PI 30
%
 o
f B
as
al
 R
el
ea
se
60
70
80
90
100
110
120
130
Sham gp
Ischemic gp
Figure 2 The glutamate in the cerebrospinal fluid has no
change during femoral artery occlusion and after the femoral
artery reperfusion. Data presented as mean SEM. BZ base-
line; IZ ischemia by femoral artery occlusion; PI 15Z post-
ischemia 15 minutes (after vessel clip removal); PI
30Z postischemia 30 minutes (after vessel clip removal).
Tourniquet inflation induces intrathecal glutamate release 261methanol) was added and the mixture allowed to react for
another 2 minutes. The derivatized sample was then injec-
ted onto a C18 reversed phase column and eluted at a flow
rate of 0.45 ml/min. A linear gradient from 100% eluent A
[0.1 M sodium acetate buffer, pH 6.8/acetonitrile (80:20)] to
100% eluent B [acetonitrile/double-distilled water (80:20)]
was used to separate the aminoacids. All solvents were
vacuum filtered through a 0.22-Am membrane (Millipore,
Billerica, MA, USA) and degassed by sonication before use.
External standard solutions, containing 0 M, 108 M, 107 M,
106 M, 105 M standard amino acids, were run before and
after each sample group.
Data analysis
Because of the wide variation of the baseline concentration
of glutamate, we chose to represent our results in
percentage of the mean baseline for data analysis. The
data are presented as mean standard error of the mean.
An unpaired two-tailed t test was used for statistical
analysis. A p-value <0.05 was considered statistically
significant.
Results
The intrathecal glutamate release was significantly
increased during the tourniquet inflation period, and it
returned to baseline following tourniquet deflation (Fig. 1).
However, there was no change of the glutamate release
during femoral artery occlusion (Fig. 2).
Discussion
The results demonstrated an increase of glutamate release
in cerebrospinal fluid during hindlimb tourniquet inflation in
rats, and no change of glutamate release during femoralB T PT 15 PT 30
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Figure 1 The glutamate release in the cerebrospinal fluid is
significantly increased during the period of tourniquet infla-
tion, and it returned to basal level after tourniquet deflation.
Data presented as mean SEM. # p< 0.05 compared with
control group. BZ baseline; TZ tourniquet inflation; PT
15Z post tourniquet deflation 15 minutes; PT 30Z post tour-
niquet deflation 30 minutes.arterial occlusion. According to the nociresponsive role of
glutamate, we hypothesized that tourniquet-induced
painful sensation might be mainly caused by compression
of the nerves or the tissues with sensory innervation
beneath tourniquet cuff rather than the tourniquet-
induced tissue ischemia, especially in the initial phase.
Regarding the possible mechanisms of tourniquet-
induced pain, the unmyelinated, slow-conducting C-fibers
have been reported to be involved.4e6 Chabel et al4
recorded microfilaments firing in an animal model of
tourniquet-induced ischemia and demonstrated that
a group of spontaneously active fibers with slow firing rates
and conduction velocities in the C-fiber range were not
found prior to tourniquet inflation. MacIver et al5 used an
in vitro study under metabolic perturbations associated
tourniquet ischemia (hypoxia, hypoglycemia, lactic acid,
and decreased pH) and showed that neither hypoxia nor
hypoglycemia alone or in combination caused A-d fibers to
become spontaneously active, but these conditions could
increase the C-fibers’ action potential frequency. Crews
et al6 used neurophysiologic recording of the spinal cord
neurons and found that compression and ischemia during
the maintenance of tourniquet inflation resulted in
a reduction inactivity of the low threshold mechanorecep-
tors of dorsal horn neurons and marked increasing of the
spontaneous firing rate of the high threshold nociresponsive
neurons. Activation of nociceptive afferents will produce
excitatory amino acids release at the first synapses within
the spinal cord dorsal horn.2,7 Prolonged firing of C-fiber
nociceptors may cause the release of glutamate, which acts
on N-methyl-D-aspartic acid (NMDA) receptors in the spinal
cord.8 Takada et al9 found that preadministration of low-
dose ketamine (0.1 mg/kg), an NMDA receptor antagonist,
attenuates tourniquet pain and prolongs tourniquet time
during high-pressure tourniquet application in healthy
volunteers. Segerdahl et al10 also demonstrated a decrease
of tourniquet-associated pain by pretreatment of low-dose
ketamine in healthy volunteers. In a laboratory study, Lee
262 C.-H. Cherng et al.et al11 reported that intravenous administration of ket-
amine before tourniquet inflation suppressed spinal c-fos
mRNA expression in rats. It is thought that the expression of
Fos protein in spinal dorsal horn neurons could be induced
by afferent nociceptive stimulations.12
It has been proposed that the tourniquet pain includes
two separate components, pressure pain and ischemic
pain.1 Pressure pain is induced by the compression of nerve
fibers beneath the tourniquet cuff, and ischemic pain is
associated with the tissue ischemia produced by
tourniquet-induced arterial occlusion. Currently, femoral
arterial ligation represents a common model used to
investigate peripheral ischemic pain.13 Mostly, these
studies were to examine the possible mechanisms of
chronic ischemic pain. The acute painful phenomenon just
following arterial occlusion was seldom researched.
According to the result of the current study that femoral
artery occlusion did not influence the spinal glutamate
release, we hypothesized that the painful sensation
induced by tourniquet, especially in the initial phase, is
mainly caused by compression of the tissues with sensory
innervation beneath cuff such as nerve itself, muscle, and
periosteum. Ischemia alone is unlikely to generate pain in
the beginning of tourniquet inflation. Ludwig et al14 re-
ported that acute ischemia-reperfusion injury induced by
femoral artery ligation in Wistar rats did not produce
painful symptoms. Clinically, pain sensation is one of the
symptoms of peripheral artery occlusion disease; however,
the pain does not occur at rest, but with exercise or on
critical limb ischemia.15 In the presents study, the rats were
immobilized by intraperitoneal pentobarbital anesthesia
during the experimental course. This situation is similar to
the clinical resting condition.
In this study, the animals were anesthetized during
experimental period, to allow smooth collection of dialy-
sates, thus no pain behavior measurement was done.
Therefore, it is difficult to conclude whether the increase
or no change of intrathecal glutamate release during hin-
dlimb tourniquet inflation or femoral artery occlusion is
related to tourniquet pain. However, the result that intra-
thecal glutamate release was increased during hindlimb
tourniquet inflation but not during femoral artery occlu-
sion, may provide a new direction for future tourniquet
pain-related studies.
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